EDGAR Filing Documents for 0001564590-22-023676

Form 8-K - Current report:

SEC Accession No. 0001564590-22-023676

Filing Date

2022-06-21

Accepted

2022-06-21 08:37:10

Documents

Period of Report

2022-06-19

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	acer-8k_20220619.htm iXBRL	8-K	54326
2	EX-10.1	acer-ex101_8.htm	EX-10.1	58572
3	EX-99.1	acer-ex991_6.htm	EX-99.1	16361
4	EX-99.2	acer-ex992_7.htm	EX-99.2	29703
5	GRAPHIC	g2xdog33hrr1000001.jpg	GRAPHIC	17440
6	GRAPHIC	g2xdog33hrr1000002.jpg	GRAPHIC	5740
7	GRAPHIC	g4qguukpr1hv000001.jpg	GRAPHIC	17440
	Complete submission text file	0001564590-22-023676.txt		378672

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	acer-20220619.xsd	EX-101.SCH	5581
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	acer-20220619_lab.xml	EX-101.LAB	20086
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	acer-20220619_pre.xml	EX-101.PRE	11931
12	EXTRACTED XBRL INSTANCE DOCUMENT	acer-8k_20220619_htm.xml	XML	3694

Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458

Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100

Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)